The subgroup of patients with thymoma‐associated MG and NMT showed reactivities to known (CASPR2/LGI1) and to the recently identified (Netrin‐1 receptors) neuronal cell‐surface antibodies. Here, CNTNAP2 is linked to myasthenia gravis.